Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes
Open Access
- 30 June 2006
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 44 (6), 1055-1065
- https://doi.org/10.1016/j.jhep.2005.10.030
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6Cancer Research, 2004
- The Bcl-2 family: roles in cell survival and oncogenesisOncogene, 2003
- Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathwaysOncogene, 2003
- Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growthHepatology, 2003
- Transcriptional Regulation of Heme Oxygenase-1 Gene Expression by MAP Kinases of the JNK and p38 Pathways in Primary Cultures of Rat HepatocytesPublished by Elsevier BV ,2003
- The Phosphotidyl Inositol 3-Kinase/Akt Signal Pathway Is Involved in Interleukin-6-mediated Mcl-1 Upregulation and Anti-apoptosis Activity in Basal Cell Carcinoma CellsJournal of Investigative Dermatology, 2002
- The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathwayOncogene, 2001
- Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesisBiochemical Journal, 2001
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- Interleukin‐6 functions as an autocrine growth factor in a cholangiocarcinoma cell lineJournal of Gastroenterology and Hepatology, 1994